# Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia

> **NCT00095719** · PHASE3 · COMPLETED · sponsor: **Otsuka Pharmaceutical Development & Commercialization, Inc.** · enrollment: 125 (—)

## Conditions studied

- Dementia
- Alzheimer's Disease

## Interventions

- **DRUG:** Aripiprazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00095719
- **Lead sponsor:** Otsuka Pharmaceutical Development & Commercialization, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2005-03
- **Final completion:** 2005-03
- **Target enrollment:** 125 (—)
- **Last updated:** 2013-11-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00095719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00095719, "Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00095719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*